1. Home
  2. CADL vs VBNK Comparison

CADL vs VBNK Comparison

Compare CADL & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.88

Market Cap

551.7M

Sector

Health Care

ML Signal

HOLD

Logo VersaBank

VBNK

VersaBank

HOLD

Current Price

$17.32

Market Cap

606.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
VBNK
Founded
1999
1980
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
551.7M
606.0M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
CADL
VBNK
Price
$8.88
$17.32
Analyst Decision
Strong Buy
Buy
Analyst Count
7
2
Target Price
$19.00
$13.00
AVG Volume (30 Days)
2.2M
83.1K
Earning Date
05-14-2026
06-03-2026
Dividend Yield
N/A
0.41%
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
$30.02
Revenue Next Year
N/A
$27.30
P/E Ratio
N/A
$25.91
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$10.10
52 Week High
$9.26
$19.02

Technical Indicators

Market Signals
Indicator
CADL
VBNK
Relative Strength Index (RSI) 75.99 50.24
Support Level $4.80 $15.74
Resistance Level N/A $17.42
Average True Range (ATR) 0.52 0.53
MACD 0.18 -0.15
Stochastic Oscillator 84.41 17.21

Price Performance

Historical Comparison
CADL
VBNK

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About VBNK VersaBank

VersaBank is a Schedule I Canadian bank that provides mainly commercial lending and banking services to select niche markets in Canada and the United States. Its products and services include credit assets, deposits, and cybersecurity services through its wholly owned subsidiary. The bank operates through four segments: Digital Banking Canada and Digital Banking USA, both using a business-to-business model with proprietary financial technology to serve underserved markets; DRTC, which provides cybersecurity services and banking and financial technology development; and Digital Meteor, which owns proprietary technology supporting next-generation digital assets, including Real Bank Deposit Tokens (RBDTs). The majority of revenue comes from Digital Banking.

Share on Social Networks: